SAM
Simplify Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
3,697
+939
| +34% | +$493K | 0.1% | 38 |
|
|
2025
Q1 | $1.75M | Sell |
2,758
-3,500
| -56% | -$2.22M | 0.07% | 52 |
|
|
2024
Q4 | $4.46M | Sell |
6,258
-3,333
| -35% | -$2.37M | 0.22% | 26 |
|
|
2024
Q3 | $10.1M | Buy |
9,591
+3,231
| +51% | +$3.4M | 0.47% | 22 |
|
|
2024
Q2 | $6.68M | Buy |
6,360
+3,310
| +109% | +$3.48M | 0.45% | 14 |
|
|
2024
Q1 | $2.94M | Sell |
3,050
-958
| -24% | -$922K | 0.17% | 35 |
|
|
2023
Q4 | $3.52M | Sell |
4,008
-294
| -7% | -$258K | 0.32% | 18 |
|
|
2023
Q3 | $3.54M | Buy |
4,302
+583
| +16% | +$480K | 0.4% | 21 |
|
|
2023
Q2 | $2.67M | Sell |
3,719
-83
| -2% | -$59.6K | 0.35% | 32 |
|
|
2023
Q1 | $3.12M | Sell |
3,802
-133
| -3% | -$109K | 0.45% | 18 |
|
|
2022
Q4 | $2.84M | Buy |
3,935
+315
| +9% | +$227K | 0.44% | 13 |
|
|
2022
Q3 | $2.49M | Buy |
3,620
+1,125
| +45% | +$775K | 0.27% | 15 |
|
|
2022
Q2 | $1.48M | Buy |
+2,495
| New | +$1.48M | 0.06% | 16 |
|